This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
April 2, 2013 /PRNewswire/ --
Chesapeake Urology Associates, PA, the premier urology practice in
Maryland and the Mid-Atlantic region, has launched a comprehensive website devoted strictly to its Prostate Cancer Care Program.
The site, with a URL of
http://prostatecancer.chesapeakeurology.com, is an easy-to-access body of information that was built for prostate cancer patients and consumers alike. It provides detail on how prostate cancer is diagnosed, treatment options for different stages of the disease, answers to frequently asked questions, a glossary of terms and recommended questions to ask at a physician appointment. This informational source gives patients more detail and perspective about prostate cancer, and enables them to select the treatment pathway that is right for them.
In addition, the site outlines the Chesapeake Urology Prostate Cancer Care Program, including its mission, experts, clinical trials, support networks and patient resources. There are also patient stories, blogs and information about the Zero Prostate Cancer Challenge, which features a 5K run, a 1 mile walk and free prostate cancer screenings held each September during National Prostate Cancer Awareness Month.
"The new website serves as an informational tool to help people learn more about prostate cancer and the high level of care provided by Chesapeake Urology physicians and staff," says
Benjamin Lowentritt, M.D., director of Chesapeake Urology's Prostate Cancer Care program. "It also demonstrates Chesapeake Urology's leadership, experience and commitment to the fight against prostate cancer."
According to Dr. Lowentritt, 1 in every 6 men will get prostate cancer sometime in his life. About 241,740 new cases of prostate cancer were diagnosed in 2012 - on par with breast cancer. In addition, the chances of getting prostate cancer are 1 in 3 if you have just one close relative (father, brother) with the disease. The risk is 83 percent with two close relatives and 97 percent with three.